Clinical Trials Browser

Has results × Smoldering Multiple Myeloma × ibrutinib × Clear all

NCT02943473 2020-12-16

Study on the Effect of Ibrutinib on High Risk Smoldering Multiple Myeloma Patients

Phase 2 Terminated

9 enrolled 6 charts

Smoldering Multiple Myeloma, Neoplasms, Plasma Cell